HK186196A - Antagonist to interleukin-5 for preventing or reducing eosinophilia - Google Patents

Antagonist to interleukin-5 for preventing or reducing eosinophilia

Info

Publication number
HK186196A
HK186196A HK186196A HK186196A HK186196A HK 186196 A HK186196 A HK 186196A HK 186196 A HK186196 A HK 186196A HK 186196 A HK186196 A HK 186196A HK 186196 A HK186196 A HK 186196A
Authority
HK
Hong Kong
Prior art keywords
antagonist
preventing
interleukin
reducing eosinophilia
reducing
Prior art date
Application number
HK186196A
Other languages
English (en)
Inventor
Robert L Coffman
Donna M Rennick
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23016493&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK186196(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK186196A publication Critical patent/HK186196A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Optical Head (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pens And Brushes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lubricants (AREA)
HK186196A 1988-11-03 1996-10-03 Antagonist to interleukin-5 for preventing or reducing eosinophilia HK186196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26690988A 1988-11-03 1988-11-03

Publications (1)

Publication Number Publication Date
HK186196A true HK186196A (en) 1996-10-11

Family

ID=23016493

Family Applications (1)

Application Number Title Priority Date Filing Date
HK186196A HK186196A (en) 1988-11-03 1996-10-03 Antagonist to interleukin-5 for preventing or reducing eosinophilia

Country Status (17)

Country Link
EP (2) EP0367596B1 (xx)
JP (1) JPH07563B2 (xx)
KR (1) KR960002183B1 (xx)
AT (1) ATE98872T1 (xx)
AU (1) AU633034B2 (xx)
CA (1) CA2002144C (xx)
DE (1) DE68911653T2 (xx)
DK (1) DK81691D0 (xx)
ES (1) ES2062032T3 (xx)
HK (1) HK186196A (xx)
IE (1) IE63063B1 (xx)
IL (1) IL92180A (xx)
MY (1) MY107386A (xx)
NZ (1) NZ243939A (xx)
PH (1) PH26476A (xx)
WO (1) WO1990004979A2 (xx)
ZA (1) ZA898322B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683836B2 (en) * 1992-02-06 1997-11-27 Schering Corporation Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
EP0681589A1 (en) * 1993-02-01 1995-11-15 Université Libre de Bruxelles Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
GB9412230D0 (en) * 1994-06-17 1994-08-10 Celltech Ltd Interleukin-5 specific recombiant antibodies
US5683892A (en) * 1994-12-23 1997-11-04 Smithkline Beecham Corporation DNA encoding recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
DE69535319T2 (de) * 1994-12-23 2007-07-19 Smithkline Beecham Corp. Rekombinante il-5 antagonisten für die behandlung von il-5 bedingten krankheiten
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US7399837B2 (en) 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
MXPA04009418A (es) * 2002-03-29 2005-06-08 Schering Corp Anticuerpos monoclonales humanos par interleucina-5, y metodos y composiciones que comprenden los mismos.
MX2010010667A (es) 2008-03-28 2010-11-09 Glaxosmithkline Llc Metodos de tratamiento.
US11390671B2 (en) 2017-06-06 2022-07-19 Glaxosmithkline Llc Biopharmaceutical compositions and methods for pediatric patients
CN109942706A (zh) * 2017-12-21 2019-06-28 三生国健药业（上海）股份有限公司 结合人il-5的单克隆抗体、其制备方法和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3854741T3 (de) * 1987-06-24 2002-08-14 Autoimmune Inc Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.

Also Published As

Publication number Publication date
IL92180A (en) 1997-04-15
EP0441891A1 (en) 1991-08-21
AU4644889A (en) 1990-05-28
CA2002144C (en) 2000-03-28
EP0367596B1 (en) 1993-12-22
DK81691A (da) 1991-05-02
NZ243939A (en) 1997-07-27
CA2002144A1 (en) 1990-05-03
MY107386A (en) 1995-11-30
ATE98872T1 (de) 1994-01-15
JPH07563B2 (ja) 1995-01-11
DE68911653D1 (de) 1994-02-10
IE63063B1 (en) 1995-03-22
KR960002183B1 (ko) 1996-02-13
DE68911653T2 (de) 1994-04-07
IL92180A0 (en) 1990-07-26
AU633034B2 (en) 1993-01-21
ES2062032T3 (es) 1994-12-16
IE893525L (en) 1990-05-03
KR900701320A (ko) 1990-12-01
WO1990004979A8 (en) 2005-06-16
ZA898322B (en) 1990-11-28
EP0367596A1 (en) 1990-05-09
DK81691D0 (da) 1991-05-02
PH26476A (en) 1992-07-27
JPH03505211A (ja) 1991-11-14
WO1990004979A2 (en) 1990-05-17

Similar Documents

Publication Publication Date Title
ZA89766B (en) Method of reducing immunoglobulin e.responses
EP0597829A4 (en) NEW MONOCLONAL ANTIBODY DRESSES AGAINST A NEW ANTIGEN ASSOCIATED WITH HUMAN TUMORS.
SG42954A1 (en) Antibody to human interleukin-6 receptor
GR3022969T3 (en) Products for the treatment of endotoxic shock in a mammal
ZA887987B (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
HK186196A (en) Antagonist to interleukin-5 for preventing or reducing eosinophilia
EP0216454A3 (en) Method of promoting animal growth
GB8910395D0 (en) Human monoclonal antibody and hybridoma producing the same
WO1991007986A8 (en) Method of treating septic shock
ZA912138B (en) Bcrf1 antagonists for treating epstein-barr virus infections
EP0407430A4 (en) Therapeutic murine monoclonal antibody
CS495286A1 (en) Mouse lymhocytaric hybridom producing antibody against human choriogonadotropic hormone

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)